The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma

The Journal of Urology
Yun-Ching HuangChing-Fang Wu

Abstract

Nephroureterectomy with bladder cuff excision may not be sufficient as monotherapy for patients with pT3N0M0 upper tract urothelial carcinoma. The efficacy of postoperative adjuvant chemotherapy in this setting remains controversial. We evaluated the efficacy of adjuvant chemotherapy for patients with pT3N0M0 upper tract urothelial carcinoma in overall, cancer specific and recurrence-free survival. We retrospectively reviewed records on 171 consecutive patients with pT3N0M0 upper tract urothelial carcinoma treated with radical nephroureterectomy between 2004 and 2014 at 2 branches of the same institution. Postoperative adjuvant chemotherapy was gemcitabine/cisplatin or cisplatin/fluorouracil/leucovorin. Overall, cancer specific and recurrence-free survival rates were estimated using the Kaplan-Meier method. The values of prognostic factors were evaluated by Cox regression analysis. Postoperative adjuvant chemotherapy was administered in 60 patients vs nonadjuvant therapy in 111 patients. Median followup was 35.8 months. Between the adjuvant and nonadjuvant treatment groups there were statistically significant differences in 5-year cancer specific (80.5% vs 57.6%, p = 0.010) and recurrence-free (74.4% vs 52.9%, p = 0.026) surviv...Continue Reading

References

Oct 12, 2000·The Journal of Urology·J J Munoz, L M Ellison
Jun 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Wen-Cheng ChenJi-Hong Hong
Aug 29, 2003·The New England Journal of Medicine·H Barton GrossmanE David Crawford
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BamiasM A Dimopoulos
Jan 22, 2009·Cancer·Vitaly MargulisUNKNOWN Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration
Aug 16, 2011·Lancet·Andrew S Levey, Josef Coresh
Apr 2, 2013·European Urology·Morgan RouprêtUNKNOWN European Association of Urology
Aug 9, 2013·Science Translational Medicine·Song Ling PoonBin Tean Teh

❮ Previous
Next ❯

Citations

Dec 3, 2016·Scientific Reports·Yun-Ching HuangChia-Hsuan Lai
Oct 30, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·I-Hung ShaoSee-Tong Pang
Jan 4, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas SeisenSteven L Chang
Jan 10, 2021·Virchows Archiv : an International Journal of Pathology·Tomoyasu SanoToyonori Tsuzuki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.